$360 Million is the total value of Altium Capital Management LP's 124 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 338.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VRCA | Buy | VERRICA PHARMACEUTICALS INC | $8,529,000 | +581.2% | 562,954 | +417.4% | 2.37% | +407.1% |
| PROG | New | PROGENITY INC | $8,322,000 | – | 1,748,252 | +100.0% | 2.31% | – |
| CHAQ | Buy | CHARDAN HEALTHCR ACQSTN 2 CO | $7,571,000 | +90.9% | 753,374 | +93.7% | 2.10% | +41.9% |
| EPIX | Buy | ESSA PHARMA INC | $6,683,000 | +219.9% | 230,063 | +31.4% | 1.86% | +137.8% |
| ALDX | New | ALDEYRA THERAPEUTICS INC | $6,513,000 | – | 548,225 | +100.0% | 1.81% | – |
| PTGX | Buy | PROTAGONIST THERAPEUTICS INC | $6,173,000 | +64.7% | 238,354 | +28.2% | 1.71% | +22.5% |
| LNTH | Buy | LANTHEUS HLDGS INC | $5,878,000 | +66.0% | 275,066 | +4.8% | 1.63% | +23.4% |
| CDNA | New | CAREDX INC | $5,535,000 | – | 81,284 | +100.0% | 1.54% | – |
| PODD | Buy | INSULET CORP | $5,479,000 | +32.3% | 21,000 | +29.6% | 1.52% | -1.6% |
| OCUL | Buy | OCULAR THERAPEUTIX INC | $5,313,000 | -15.3% | 326,174 | +7.6% | 1.48% | -37.0% |
| AUPH | Buy | AURINIA PHARMACEUTICALS INC | $5,310,000 | +30.6% | 408,908 | +39.1% | 1.47% | -2.9% |
| NVRO | New | NEVRO CORP | $5,287,000 | – | 37,900 | +100.0% | 1.47% | – |
| TVTX | Buy | TRAVERE THERAPEUTICS INC | $5,256,000 | +152.1% | 210,484 | +175.2% | 1.46% | +87.5% |
| MBTCU | New | NOCTURNE ACQUISITION CORPunit 02/25/2026 | $5,000,000 | – | 500,000 | +100.0% | 1.39% | – |
| CLSN | New | CELSION CORP | $4,825,000 | – | 3,496,154 | +100.0% | 1.34% | – |
| RYTM | New | RHYTHM PHARMACEUTICALS INC | $4,743,000 | – | 223,000 | +100.0% | 1.32% | – |
| TCRR | Buy | TCR2 THERAPEUTICS INC | $4,618,000 | +101.7% | 209,130 | +182.6% | 1.28% | +49.9% |
| FBRX | New | FORTE BIOSCIENCES INC | $4,611,000 | – | 134,542 | +100.0% | 1.28% | – |
| MREO | New | MEREO BIOPHARMA GROUP PLCads | $4,213,000 | – | 1,250,000 | +100.0% | 1.17% | – |
| HARP | Buy | HARPOON THERAPEUTICS INC | $4,176,000 | +146.5% | 199,607 | +95.7% | 1.16% | +83.4% |
| RNA | New | AVIDITY BIOSCIENCES INC | $3,895,000 | – | 178,600 | +100.0% | 1.08% | – |
| CTMX | Buy | CYTOMX THERAPEUTICS INC | $3,734,000 | +108.3% | 483,041 | +76.5% | 1.04% | +54.9% |
| CNST | Buy | CONSTELLATION PHARMCETICLS I | $3,713,000 | -4.0% | 158,733 | +18.3% | 1.03% | -28.6% |
| IMVT | Buy | IMMUNOVANT INC | $3,683,000 | +2.7% | 229,622 | +195.8% | 1.02% | -23.6% |
| TFFP | New | TFF PHARMACEUTICALS INC | $3,660,000 | – | 269,691 | +100.0% | 1.02% | – |
| NBEV | New | NEWAGE INC | $3,427,000 | – | 1,198,150 | +100.0% | 0.95% | – |
| GKOS | New | GLAUKOS CORP | $3,424,000 | – | 40,800 | +100.0% | 0.95% | – |
| ARQT | Buy | ARCUTIS BIOTHERAPEUTICS INC | $3,297,000 | +86.2% | 113,962 | +81.0% | 0.92% | +38.4% |
| KALV | New | KALVISTA PHARMACEUTICALS INC | $3,292,000 | – | 128,130 | +100.0% | 0.91% | – |
| INFI | New | INFINITY PHARMACEUTICALS INC | $3,141,000 | – | 972,327 | +100.0% | 0.87% | – |
| IFRX | New | INFLARX NV | $3,021,000 | – | 774,600 | +100.0% | 0.84% | – |
| GMED | Buy | GLOBUS MED INCcl a | $3,013,000 | +46.6% | 48,862 | +55.1% | 0.84% | +9.0% |
| XENT | Buy | INTERSECT ENT INC | $2,962,000 | +29.8% | 141,856 | +42.3% | 0.82% | -3.5% |
| MORF | New | MORPHIC HLDG INC | $2,945,000 | – | 46,541 | +100.0% | 0.82% | – |
| EYPT | New | EYEPOINT PHARMACEUTICALS INC | $2,939,000 | – | 289,316 | +100.0% | 0.82% | – |
| NUVA | New | NUVASIVE INC | $2,828,000 | – | 43,133 | +100.0% | 0.78% | – |
| GMTX | New | GEMINI THERAPEUTICS INC | $2,764,000 | – | 203,995 | +100.0% | 0.77% | – |
| PHAS | New | PHASEBIO PHARMACEUTICALS INC | $2,682,000 | – | 775,000 | +100.0% | 0.74% | – |
| DYN | New | DYNE THERAPEUTICS INC | $2,588,000 | – | 166,636 | +100.0% | 0.72% | – |
| CFMS | New | CONFORMIS INC | $2,583,000 | – | 2,608,875 | +100.0% | 0.72% | – |
| PROF | New | PROFOUND MED CORP | $2,546,000 | – | 126,427 | +100.0% | 0.71% | – |
| CYTK | New | CYTOKINETICS INC | $2,402,000 | – | 103,262 | +100.0% | 0.67% | – |
| WVE | New | WAVE LIFE SCIENCES LTD | $2,238,000 | – | 398,997 | +100.0% | 0.62% | – |
| MEIP | New | MEI PHARMA INC | $2,189,000 | – | 638,083 | +100.0% | 0.61% | – |
| VREX | New | VAREX IMAGING CORP | $2,166,000 | – | 105,727 | +100.0% | 0.60% | – |
| ADMS | New | ADAMAS PHARMACEUTICALS INC | $2,160,000 | – | 450,000 | +100.0% | 0.60% | – |
| MCRB | New | SERES THERAPEUTICS INC | $2,154,000 | – | 104,626 | +100.0% | 0.60% | – |
| PXS | New | PYXIS TANKERS INC | $2,097,000 | – | 2,035,793 | +100.0% | 0.58% | – |
| CALA | New | CALITHERA BIOSCIENCES INC | $2,066,000 | – | 853,902 | +100.0% | 0.57% | – |
| HCAQ | New | HEALTHCOR CATALIO ACQU CORP | $2,000,000 | – | 200,000 | +100.0% | 0.56% | – |
| FSII | New | FS DEVELOPMENT CORP II | $1,992,000 | – | 200,000 | +100.0% | 0.55% | – |
| YMTX | New | YUMANITY THERAPEUTICS INC | $1,967,000 | – | 108,695 | +100.0% | 0.55% | – |
| MGTA | New | MAGENTA THERAPEUTICS INC | $1,946,000 | – | 164,381 | +100.0% | 0.54% | – |
| LCY | New | LANDCADIA HOLDINGS III INC | $1,925,000 | – | 192,314 | +100.0% | 0.53% | – |
| ACEV | New | ACE CONVERGENCE ACQU CORPcl a | $1,884,000 | – | 189,000 | +100.0% | 0.52% | – |
| ACET | New | ADICET BIO INC | $1,861,000 | – | 142,289 | +100.0% | 0.52% | – |
| SLRX | New | SALARIUS PHARMACEUTICALS INC | $1,850,000 | – | 1,250,110 | +100.0% | 0.51% | – |
| STIM | New | NEURONETICS INC | $1,701,000 | – | 137,500 | +100.0% | 0.47% | – |
| BWAY | New | BRAINSWAY LTDsponsored ads | $1,621,000 | – | 179,506 | +100.0% | 0.45% | – |
| XGN | New | EXAGEN INC | $1,513,000 | – | 86,475 | +100.0% | 0.42% | – |
| CMLF | New | CM LIFE SCIENCES INC | $1,489,000 | – | 100,000 | +100.0% | 0.41% | – |
| VLON | New | VALLON PHARMACEUTICALS INC | $1,392,000 | – | 300,000 | +100.0% | 0.39% | – |
| TWND | New | TAILWIND ACQUISITION CORP | $1,274,000 | – | 128,414 | +100.0% | 0.35% | – |
| VRAY | New | VIEWRAY INC | $1,258,000 | – | 289,114 | +100.0% | 0.35% | – |
| GIGGU | New | GIGCAPITAL4 INCunit 99/99/9999 | $1,234,000 | – | 125,000 | +100.0% | 0.34% | – |
| ARYD | New | ARYA SCIENCES ACQU CORP IVcl a | $1,047,000 | – | 100,000 | +100.0% | 0.29% | – |
| AJAX | New | AJAX I | $1,026,000 | – | 100,000 | +100.0% | 0.28% | – |
| QELL | New | QELL ACQUISITION CORPcl a | $1,018,000 | – | 100,000 | +100.0% | 0.28% | – |
| SPNV | New | SUPERNOVA PARTNERS ACQUISITI | $1,011,000 | – | 100,000 | +100.0% | 0.28% | – |
| CCAC | New | CITIC CAPITAL ACQUISITION CO | $1,000,000 | – | 100,000 | +100.0% | 0.28% | – |
| FMAC | New | FIRSTMARK HORIZON ACQUISITIO | $1,000,000 | – | 100,000 | +100.0% | 0.28% | – |
| MOTV | New | MOTIVE CAPITAL CORP | $1,001,000 | – | 102,099 | +100.0% | 0.28% | – |
| OMEG | New | OMEGA ALPHA SPACcl a | $990,000 | – | 100,000 | +100.0% | 0.28% | – |
| SYRS | New | SYROS PHARMACEUTICALS INC | $948,000 | – | 126,702 | +100.0% | 0.26% | – |
| CHAQWS | Buy | CHARDAN HEALTHCR ACQSTN 2 CO*w exp 03/05/202 | $688,000 | +39.0% | 731,561 | +46.3% | 0.19% | +3.2% |
| BCTXW | New | BRIACELL THERAPEUTICS CORP*w exp 02/24/202 | $535,000 | – | 500,000 | +100.0% | 0.15% | – |
| VERB | New | VERB TECHNOLOGY CO INC | $394,000 | – | 281,173 | +100.0% | 0.11% | – |
| CMLFW | New | CM LIFE SCIENCES INC*w exp 09/04/202 | $345,000 | – | 66,666 | +100.0% | 0.10% | – |
| EVAX | New | EVAXION BIOTECH A Sads | $146,000 | – | 24,725 | +100.0% | 0.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-06
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FAT BRANDS INC | 12 | Q3 2023 | 0.6% |
| CHINOOK THERAPEUTICS INC | 11 | Q2 2023 | 8.9% |
| BELLUS HEALTH INC NEW | 10 | Q1 2023 | 4.7% |
| XTANT MED HLDGS INC | 10 | Q3 2023 | 5.1% |
| IVERIC BIO INC | 10 | Q1 2023 | 2.3% |
| MYRIAD GENETICS INC | 10 | Q1 2023 | 2.3% |
| HARBOR CUSTOM DEVELOPMENT IN | 10 | Q3 2023 | 0.1% |
| CRINETICS PHARMACEUTICALS IN | 9 | Q3 2023 | 4.1% |
| CTI BIOPHARMA CORP | 9 | Q1 2023 | 2.6% |
| POLISHED COM INC | 9 | Q2 2023 | 3.4% |
View Altium Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Marpai, Inc. | April 26, 2023 | 1,805,327 | 6.2% |
| Astria Therapeutics, Inc. | February 14, 2023 | 1,355,372 | 5.0% |
| HyreCar Inc. | February 14, 2023 | 1,688,120 | 5.6% |
| Muscle Maker, Inc. | February 14, 2023 | 2,888,085 | 5.0% |
| NeuroBo Pharmaceuticals, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| PALISADE BIO, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| 1847 Goedeker Inc. | February 14, 2022 | 6,103,824 | 5.0% |
| BioRestorative Therapies, Inc. | February 14, 2022 | 200,000 | 5.0% |
| BriaCell Therapeutics Corp. | February 14, 2022 | 900,000 | 4.7% |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | February 14, 2022 | 363,000 | 5.0% |
View Altium Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-02-21 |
| SC 13G | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View Altium Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.